|Day's Range||64.13 - 64.43|
|52 Week Range||49.14 - 64.43|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.58%|
Categories: Yahoo Finance Click here to see latest analysis Sartorius Stedim Biotech SA reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Sartorius Stedim Biotech SA – Smith & Nephew plc (SN-GB) that have also reported for this period. Highlights Summary numbers: Revenues of EUR 263 million, ... Read more (Read more...)
Click here to see latest analysisSartorius Stedim Biotech SA reports financial results for the quarter ended March 31, 2016.HighlightsSummary numbers: Revenues of EUR 245.80 million, Net Earnings of EUR 36.40 million.Gross margins widened from 50.29% to 51.06% compared to the same period last year, operating (EBITDA) margins now 26.44% from 24.80%.Change in operating cash flow […] (Read more...) The post Sartorius Stedim Biotech SA :DIM-FR: Earnings Analysis: Q1, 2016 By the Numbers : June 13, 2016 appeared first on CapitalCube.
Discover which three mid-cap ETFs with high expense ratios have attractive valuation and return parameters that make them excellent places to invest.